Story upgraded mid-call: management spontaneously tops its own prepared version with fresher or bigger facts
The model's full reasoning — Q2 2023 call → NOWe need to determine if management spontaneously upgrades its own story relative to its prepared version during the call. The prepared remarks are the initial statements by Amir London and Chaime Orlev. Then there is Q&A. We need to see if in the Q&A or any unscripted part, management volunteers positive developments that go beyond the prepared version, in terms of bigger, faster, broader, more recent, etc. Let's review the transcript. The prepared remarks include: strong Q2 results, reiterating guidance, KEDRAB extension, FDA approval for CYTOGAM manufacturing, Health Canada approval, InnovAATe enrollment at 62 patients, EMA positive advice, etc. They also mention the FIMI investment. In the Q&A, the first question from Annabel Samimy about InnovAATe and FDA. Amir responds: "We have -- we don't have any challenges or issue with the FDA regarding the design of the study. The study was designed in a harmonized fashion between the EMA and the FDA. It's under an FDA/IND. Just based on the sequence of the meeting that we plan to do today and generating the ongoing data, we started with a meeting with the EMA, and we had the scientific advice discussion with them. And we plan on submitting the data to the FDA and kind of reporting the progress to date by end of this year, including getting the feedback. Both agencies, EMA and FDA, are supportive of the FEV1 endpoint as our primary endpoint of the study. And what we reiterated in today's release is that we were very -- highly encouraged by the positive feedback we received from the EMA that included reconfirmation of the overall design of the study and acknowledging the statistically and clinically meaningful improvement in the FEV1 data demonstrated in the previous European study. So we expect to receive similar feedback from the FDA upon providing the data and the progress update later this year." This is essentially restating what was in the prepared remarks. No new concrete positive development beyond that. Then Annabel asks about enrollment learnings. Amir says: "So the study is under an IND. So actually, everything we do currently is the same study, harmonize study that will meet requirements for both, submission of the BLA and MAA, of course, upon successful completion of the study.
| Ticker | Company | Call | Date | Call grade |
|---|---|---|---|---|
| AZEK | The AZEK Company Inc. | Q2 2024 | 2024-05-08 | B+ |
| AES | The AES Corporation | Q1 2024 | 2024-05-03 | C+ |
| WEC | WEC Energy Group, Inc. | Q1 2024 | 2024-05-01 | A |
| EGP | EastGroup Properties, Inc. | Q4 2023 | 2024-02-08 | B |
| PFE | Pfizer Inc. | Q4 2023 | 2024-01-30 | F |
| SCPH | scPharmaceuticals Inc. | Q3 2023 | 2023-11-08 | B |
| BZUN | Baozun Inc. | Q2 2023 | 2023-08-28 | D |
| SPT | Sprout Social, Inc. | Q2 2023 | 2023-08-04 | B+ |
| ET | Energy Transfer LP | Q2 2023 | 2023-08-02 | C+ |
| CTO | CTO Realty Growth, Inc. | Q2 2023 | 2023-07-28 | B |
| GS | The Goldman Sachs Group, Inc. | Q2 2023 | 2023-07-19 | C+ |
| GGR | Gogoro Inc. | Q1 2023 | 2023-05-11 | D |
| UAL | United Airlines Holdings, Inc. | Q4 2022 | 2023-01-18 | B |
| SIBN | SI-BONE, Inc. | Q3 2022 | 2022-11-07 | C+ |
| AWRE | Aware, Inc. | Q3 2022 | 2022-10-30 | F |
| CURV | Torrid Holdings Inc. | Q2 2022 | 2022-09-07 | D |
| XHR | Xenia Hotels & Resorts, Inc. | Q2 2022 | 2022-08-05 | A |
| TWO | Two Harbors Investment Corp. | Q2 2022 | 2022-08-04 | C+ |
| BRKL | Brookline Bancorp, Inc. | Q2 2022 | 2022-07-30 | B+ |
| LIN | Linde plc | Q2 2022 | 2022-07-28 | B+ |
| BHF | Brighthouse Financial, Inc. | Q1 2022 | 2022-05-10 | C |
| CCRN | Cross Country Healthcare, Inc. | Q1 2022 | 2022-05-04 | B |
| FLUX | Flux Power Holdings, Inc. | Q2 2022 | 2022-02-10 | D |
| GFS | GLOBALFOUNDRIES Inc. | Q3 2021 | 2021-11-30 | A |
| RNW | ReNew Energy Global Plc | Q2 2022 | 2021-11-18 | C |
| ASAN | Asana, Inc. | Q2 2022 | 2021-09-01 | B+ |
| KNDI | Kandi Technologies Group, Inc. | Q2 2021 | 2021-08-09 | F |
| CRS | Carpenter Technology Corporation | Q4 2021 | 2021-08-01 | A |
| TCBI | Texas Capital Bancshares, Inc. | Q2 2021 | 2021-07-21 | F |
| UMH | UMH Properties, Inc. | Q3 2018 | 2018-11-02 | C+ |
| AMGN | Amgen Inc. | Q3 2018 | 2018-10-30 | B+ |
| PRIM | Primoris Services Corporation | Q2 2018 | 2018-08-11 | C+ |
| ORAN | Orange SA | Q2 2018 | 2018-07-26 | B |
| USFD | US Foods Holding Corp. | Q1 2018 | 2018-05-12 | C |
| FOSL | Fossil Group, Inc. | Q1 2018 | 2018-05-08 | C |
| ALLY | Ally Financial Inc. | Q1 2018 | 2018-04-26 | B+ |
| LII | Lennox International Inc. | Q4 2017 | 2018-02-06 | B+ |
| IR | Ingersoll-Rand Plc | Q3 2017 | 2017-10-25 | B |
| PII | Polaris Inc. | Q3 2017 | 2017-10-24 | C+ |
| IBTX | Independent Bank Group, Inc. | Q3 2017 | 2017-10-24 | A |
| BCE | BCE Inc. | Q2 2017 | 2017-08-05 | B+ |
| LEA | Lear Corporation | Q2 2017 | 2017-07-26 | B+ |
| KHC | The Kraft Heinz Company | Q1 2017 | 2017-05-03 | F |
| BP | BP p.l.c. | Q4 2016 | 2017-02-07 | B+ |
| GEO | The GEO Group, Inc. | Q2 2016 | 2016-08-02 | B+ |
| ARKR | Ark Restaurants Corp. | Q1 2016 | 2016-05-13 | B |
| CAL | Caleres, Inc. | Q4 2015 | 2016-03-15 | C+ |
RNW · Q2 2022 → YESThe question is whether management spontaneously upgrades its own story relative to the prepared version during the Q&A. YES The transcript shows management spontaneously upgrading its corporate PPA story in the Q&A. In the prepared remarks, Sumant only referenced the overall corporate PPA market opportunity of at least 25 GW and noted it provides “significant upside” to guidance, without mentioning any signed volume. In the Julien Dumoulin-Smith question-and-answer 30 minutes later, Sumant volunteers the concrete fact that “we’ve already signed up about 100 megawatts worth of PPAs with corporate customers that we have now included in our total number,” and adds that more progress is expected. This is fresher, more specific, and positive relative to the prepared framing, 100 MW being a real, current commitment already folded into the 7 GW operating base.
PFE · Q4 2023 → YESThe question is whether management spontaneously upgrades its own story relative to the prepared remarks during the Q&A, volunteering positive developments that go beyond the prepared presentation, ma...**YES** In the Q&A, management spontaneously volunteers concrete, current positive developments that exceed the prepared remarks in freshness, breadth, and momentum. For example, on Prevnar, Albert directly summarizes that the U.S. adult catch-up opportunity has been exhausted with 96% market share already achieved, pediatric growth is accelerating 4-dose cohort dynamics, and international tenders plus VTC recommendations are delivering immediate traction—facts not framed this way in the opening remarks.
PRIM · Q2 2018 → YESThe question is whether management spontaneously upgrades its own story relative to the prepared remarks with positive developments that are bigger, faster, broader, or more recent. YES In the Q&A, David King spontaneously upgrades the prepared framing of the Willbros T&D awards by volunteering that the three major customers (one announced as $145M MSA, two others leaking out) were customers from the due-diligence meetings who had been hesitant about financial viability but were now actively placing awards — a fresher, broader, and more recent positive development than the prepared remarks’ single mention of “awarded work from some of the largest electrical utilities” in the first two months.